Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00051038
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2002-12-31
Brief Title:
Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-09
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2002-12-31
First Submit QC Date:
January 2 2003
Study First Post Date:
2003-01-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-01-29
Disp First Submit QC Date:
January 29 2010
Disp First Post Date:
2010-02-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-07
Last Update Post Date:
2011-04-14
Last Update Post Date Type:
ESTIMATED